NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Paul Toren
Université Laval - Quebec City / Canada
Others
AD Scientific Index ID: 655099
Laval University
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Paul Toren's MOST POPULAR ARTICLES
1-)
Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of …L Klotz, C O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Callaghan, K Ding, P Toren, D Dearnaley, CS Higano, ...Journal of Clinical Oncology 33 (10), 1151, 20151762015
2-)
Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunitiesP Toren, A ZoubeidiInternational journal of oncology 45 (5), 1793-1801, 20141452014
3-)
Combination AZD5363 with enzalutamide significantly delays enzalutamide-resistant prostate cancer in preclinical modelsP Toren, S Kim, T Cordonnier, C Crafter, BR Davies, L Fazli, ME Gleave, ...European urology 67 (6), 986-990, 20151052015
4-)
Anticancer activity of a novel selective CYP17A1 inhibitor in preclinical models of castrate-resistant prostate cancerPJ Toren, S Kim, S Pham, A Mangalji, H Adomat, EST Guns, A Zoubeidi, ...Molecular cancer therapeutics 14 (1), 59-69, 2015982015
5-)
Small incidentally discovered testicular masses in infertile men—is active surveillance the new standard of care?PJ Toren, M Roberts, I Lecker, ED Grober, K Jarvi, KC LoThe Journal of urology 183 (4), 1373-1377, 2010752010
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept